3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Dermatologic
3
Thoracic
2
Head & Neck
2
Genitourinary
2
Gastrointestinal
2
Sarcoma
1
Plasma cell
1
Other solid neoplasm
1
Other hematologic neoplasm
1
NET
1
Myeloid
1
Lymphoid
1
Gynecologic
1
Endocrine
1
CNS
1
Breast
1
Conditions
Breast Neoplasms
111
Triple Negative Breast Neoplasms
25
Lung Neoplasms
8
Pancreatic Neoplasms
6
Neoplasm Metastasis
6
Colonic Neoplasms
6
Ovarian Neoplasms
5
Neoplasms
5
Melanoma
5
Colorectal Neoplasms
5
Stomach Neoplasms
4
Head and Neck Neoplasms
4
Esophageal Neoplasms
4
Sarcoma
3
Liver Neoplasms
3
Kidney Neoplasms
3
Cholangiocarcinoma
3
Uterine Cervical Neoplasms
2
Multiple Myeloma
2
Motor Activity
2
Lymphoma, Non-Hodgkin
2
Lymphoma
2
Laryngeal Neoplasms
2
Gastrointestinal Neoplasms
2
Fatigue
2
Fallopian Tube Neoplasms
2
Carcinoma, Renal Cell
2
Carcinoma, Non-Small-Cell Lung
2
Brain Neoplasms
2
Bile Duct Neoplasms
2
Interventions
pembrolizumab
2
Interleukin-2
2
Biopsy
2
montanide ISA 51
1
liposomal doxorubicin
1
cemiplimab
1
cc-486
1
brodalumab
1
atezolizumab
1
SUB1 protein, human
1
Radiotherapy, Image-Guided
1
Quality of Life
1
Psychiatric Rehabilitation
1
Poly I-C
1
Patient Reported Outcome Measures
1
Observation
1
Molecular Diagnostic Techniques
1
Mass Screening
1
Injections
1
Immunotherapy
1
Immunohistochemistry
1
IT-101
1
Genetic Profile
1
Floderm topical cream
1
Drug Therapy
1
Camptothecin
1
CALAA-01
1
Biological Therapy
1
Azacitidine
1
2-cyclohexylidenhydrazo-4-phenyl-thiazole
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Skin Neoplasms
×
Drug Therapy
×
Breast
×
Clear all
NCT04028479
2024-12-18
ROOT
Taproot Health
Completed
167 enrolled